Recombinant Anti-CD4 (Clone MT310)
Applications | FC, IF, IHC, IP, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone MT310)
Applications | FC, IF, IHC, IP, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone 528)
Applications | FC, IF, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone 13B8.2)
Applications | EIA, ELISA, FC, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone S3 12D)
Applications | ELISA, ICC, IF, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone Matuzumab)
Applications | Bl, ELISA, FC, IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone YNB46.1.8 (Campath-9H))
Applications | FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
Applications | ELISA, FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-ERBB2 (Clone SAIC-02A-7)
Applications | ELISA, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
Applications | Bl, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone DB81)
Applications | ELISA, FC, Neutralize |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-c-erbB-2 (Clone FWP51)
Applications | FC, IF, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone EDU-2 (B486))
Applications | FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone C225 (Cetuximab))
Applications | Bl, FC |
Reactivities | Human |
Conjugation | Unconjugated |